Radiation Maculopathy Formally Recognized as Roca Therapeutics Wins First EMA Orphan Nod for RCT002
A first-in-class topical therapy aims to fill the treatment void for patients losing vision after radiotherapy. Radiation maculopathy (RM) has…
First Patients Dosed in jCyte’s Phase II JC02-88 Trial for Retinitis Pigmentosa
jCyte turns up the dose, chasing broader answers for a disease with few options. A higher dose, a broader target…
popular posts
latest posts
